PHF19 and Akt control the switch between proliferative and invasive states in melanoma
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PHF19 and Akt control the switch between proliferative and invasive states in melanoma
Authors
Keywords
-
Journal
CELL CYCLE
Volume 11, Issue 8, Pages 1634-1645
Publisher
Informa UK Limited
Online
2012-04-11
DOI
10.4161/cc.20095
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Plasticity of melanoma cells induced by neural cell crest conditions and three-dimensional growth
- (2012) Stephanie Ghislin et al. MELANOMA RESEARCH
- Functional characterization of human Polycomb-like 3 isoforms identifies them as components of distinct EZH2 protein complexes
- (2011) Gaylor Boulay et al. BIOCHEMICAL JOURNAL
- Expression analysis and molecular targeting of cyclin-dependent kinases in advanced melanoma
- (2011) Christopher Abdullah et al. CELL CYCLE
- Characterization of human melanoma cell lines and melanocytes by proteome analysis
- (2011) Emilia Caputo et al. CELL CYCLE
- The proliferation rate paradox in antimitotic chemotherapy
- (2011) Timothy J. Mitchison MOLECULAR BIOLOGY OF THE CELL
- Mitf is the key molecular switch between mouse or human melanoma initiating cells and their differentiated progeny
- (2011) Y Cheli et al. ONCOGENE
- Junctional adhesion molecules are required for melanoma cell lines transendothelial migration in vitro
- (2011) Stephanie Ghislin et al. Pigment Cell & Melanoma Research
- GLI2 and M-MITF transcription factors control exclusive gene expression programs and inversely regulate invasion in human melanoma cells
- (2011) Delphine Javelaud et al. Pigment Cell & Melanoma Research
- Differential LEF1 and TCF4 expression is involved in melanoma cell phenotype switching
- (2011) Ossia M. Eichhoff et al. Pigment Cell & Melanoma Research
- Melanoma Spheroids Grown Under Neural Crest Cell Conditions Are Highly Plastic Migratory/Invasive Tumor Cells Endowed with Immunomodulator Function
- (2011) Kiran Ramgolam et al. PLoS One
- A Switch from Canonical to Noncanonical Wnt Signaling Mediates Drug Resistance in Colon Cancer Cells
- (2011) Michael Bordonaro et al. PLoS One
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor Growth
- (2010) Alexander Roesch et al. CELL
- Cooperativity ofCdk4R24CandRasin melanoma development
- (2010) Rachna Chawla et al. CELL CYCLE
- Convergence between Wnt-β-catenin and EGFR signaling in cancer
- (2010) Tianhui Hu et al. Molecular Cancer
- CDK1-dependent phosphorylation of EZH2 suppresses methylation of H3K27 and promotes osteogenic differentiation of human mesenchymal stem cells
- (2010) Yongkun Wei et al. NATURE CELL BIOLOGY
- Cancer stem cells versus phenotype-switching in melanoma
- (2010) Keith S. Hoek et al. Pigment Cell & Melanoma Research
- The PTEN-AKT3 signaling cascade as a therapeutic target in melanoma
- (2009) SubbaRao V. Madhunapantula et al. Pigment Cell & Melanoma Research
- In vivo Switching of Human Melanoma Cells between Proliferative and Invasive States
- (2008) K. S. Hoek et al. CANCER RESEARCH
- Role of ING4 in human melanoma cell migration, invasion and patient survival
- (2008) Jun Li et al. CARCINOGENESIS
- The ING gene family in the regulation of cell growth and tumorigenesis
- (2008) Andrew H. Coles et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Chromatin immunoprecipitation (ChIP) coupled to detection by quantitative real-time PCR to study transcription factor binding to DNA in Caenorhabditis elegans
- (2008) Arnab Mukhopadhyay et al. Nature Protocols
- Downregulation of EZH2 decreases growth of estrogen receptor-negative invasive breast carcinoma and requires BRCA1
- (2008) M E Gonzalez et al. ONCOGENE
- The polycomb group protein EZH2 regulates actin polymerization in human prostate cancer cells
- (2007) R.J. Bryant et al. PROSTATE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation